Pricing

Ocera Therapeutics (OCRX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Linda S. Grais
Employees:
19
555 TWIN DOLPHIN DRIVE, SUITE 615, REDWOOD CITY, CA, 94065
6504750158

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • TRANZYME INC
Stock Split History
DateRatio
2013-07-16 1:12
Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in development and commercialization of OCR-002 (ornithine phenylacetate0 in intravenous and oral formulations. The company was founded by Wu Xiaoyun, John C. Kappes, and Eckard Weber on January 12, 1998 and is headquartered in Palo Alto, CA.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available